Palbace 125mg Tablet
Marketer
Pfizer Ltd
Salt Composition
Palbociclib (125mg)
Overview Palbace 125mg Tablet
Estrogen receptor-positive, HER2-negative metastatic breast cancer is treated with the 125mg Palbace tablet, administered concurrently with hormonal anti-cancer agents. Consistent daily dosing, ideally with meals, maximizes therapeutic efficacy. Dosage frequency and duration are determined by your physician, based on individual needs and may vary. Strict adherence to the prescribed regimen is crucial; inappropriate use carries severe risks. Benefits may not be immediately apparent, requiring weeks or months; discontinue only under medical supervision. Common side effects include nausea, hair thinning, skin reactions, vomiting, and bowel disturbances. Reduced blood cell counts increase infection vulnerability; report fever, chills, unusual bleeding, or bruising promptly. Dizziness necessitates avoidance of driving and activities requiring alertness. Prior to commencing treatment, disclose any pre-existing cardiac, hepatic, or renal conditions, along with all current medications, as drug interactions are possible. Palbace is contraindicated during pregnancy and lactation; reliable contraception is essential for both partners. A patient support program (Tata 1mg) operates in India; inquire with your doctor or call 1800-102-1618 for further information.
Uses of Palbace 125mg Tablet
Malignant breast tumor
Major Benefits of Palbace 125mg Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Palbace 125mg Tablet should be administered with food.
Common Side effects of Palbace 125mg Tablet:
- Decreased blood cells (red cells, white cells, and platelets)
- Fatigue
- Hair loss
- Rash
- Vomiting
- Diarrhea
- Nausea
- Decreased appetite
- Infection
- Decreased white blood cell count
- Stomatitis (Inflammation of the mouth)
- Anemia (low number of red blood cells)
- Weakness
- Fever
How to use Palbace 125mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Palbace 125mg tablets should be administered with a meal.
How Palbace 125mg Tablet works:
Palbociclib 125mg tablets are an anticancer drug. It functions by blocking cyclin-dependent kinases 4 and 6, key proteins driving cell growth. These kinases are part of signaling pathways that promote cellular proliferation. By inhibiting these kinases, Palbociclib halts cancer cell division and specifically targets estrogen receptor-positive breast cancer cells, disrupting their cell cycle.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Palbace 125mg Tablet may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Use of Palbace 125mg tablets is contraindicated during pregnancy due to established fetal risks. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingUNSAFE
Lactation is contraindicated with Palbace 125mg tablets due to potential infant toxicity.
DrivingUNSAFE
Driving ability may be impaired by Palbace 125mg Tablets, as they can induce fatigue in some patients. Therefore, operate machinery or vehicles with care if experiencing this symptom.
KidneySAFE IF PRESCRIBED
For patients with kidney disease, Palbace 125mg tablets are considered safe, and no dosage modification is necessary.
LiverCAUTION
Patients with liver impairment should exercise caution when using Palbace 125mg tablets, as dose modification may be necessary. Physician consultation is advised.
What if you forget to take Palbace 125mg Tablet :
NA
Facts to Know About Palbace 125mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Piperazine-pyridines |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Actions | CDK Inhibitor |
3,018 People bought this recently